Collegeville, PA, United States of America

Linda N Casillas

USPTO Granted Patents = 15 (Patent Applications = 9)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 12)

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 40(Granted Patents)

Company Filing History:

9 out of 230

Glaxosmithkline Intellectual Property Development Limited

Smithkline Beecham Corporation

patents

Years Active: 2009-2020

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10781205 - Conjugates comprising RIPK2 inhibitors (2020-09-22),

2. 10435391 - Compounds (2019-10-08),

3. 10220030 - Amino-quinolines as kinase inhibitors (2019-03-05),

4. 9994529 - Amino quinazolines as kinase inhibitors (2018-06-12),

5. 9650364 - Quinazolines as kinase inhibitors (2017-05-16),

6. 9604963 - Amino-quinolines as kinase inhibitors (2017-03-28),

7. 9604938 - Amino quinazolines as kinase inhibitors (2017-03-28),

8. 9586953 - Prodrugs of amino quinazoline kinase inhibitor (2017-03-07),

9. 9227914 - Calcilytic compounds (2016-01-05),

10. 9216965 - Amino-quinolines as kinase inhibitors (2015-12-22),

11. 8980950 - Calcilytic compounds (2015-03-17),

12. 8586631 - Calcilytic compounds (2013-11-19),

13. 8399517 - Calcilytic compounds (2013-03-19),

14. 7829594 - Calcilytic compounds (2010-11-09),

15. 7514473 - Calcilytic compounds (2009-04-07),

Title: The Innovative Brilliance of Linda N. Casillas

Introduction

Linda N. Casillas, a prominent inventor based in Collegeville, PA, has made significant contributions to the field of medicinal chemistry. With an impressive portfolio of 15 patents, her work primarily revolves around developing innovative compounds and compositions aimed at treating various diseases. Her inventions focus on inhibiting RIP2 kinase, a crucial target in the development of treatments for inflammatory conditions.

Latest Patents

Among her latest patents, Linda has developed conjugates that comprise RIPK2 inhibitors. These innovations pertain to compounds, compositions, combinations, and medicaments that involve processes for their preparation. The primary utility of these inventions lies in their capacity to inhibit the activity of RIP2 kinase, including the degradation of this kinase, thereby paving the way for new treatments for diseases mediated by RIP2 kinase. This includes pivotal work in addressing inflammatory diseases and conditions.

Career Highlights

Linda N. Casillas has built a formidable career, having worked with esteemed organizations such as GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline LLC. Her tenure at these companies has solidified her status as a leading figure in pharmaceutical research and development, particularly in the realm of innovative therapeutic solutions.

Collaborations

Throughout her career, Linda has collaborated with notable professionals, including Robert W Marquis, Jr. and Joshi M Ramanjulu. These collaborations have further enriched her work, enabling the development of groundbreaking inventions and significantly impacting the medical field.

Conclusion

Linda N. Casillas exemplifies the spirit of innovation through her extensive work in the development of compounds aimed at addressing critical health issues. Her numerous patents not only highlight her expertise as an inventor but also her commitment to improving healthcare through science and technology. The impact of her contributions is likely to resonate in the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.